Inder S. Anand

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 103 Citations 45,061 516 World Ranking 4303 National Ranking 2418

Overview

What are the main themes of his work throughout his whole career to date

While working on this project, Inder S. Anand studies both Pharmacology and Biochemistry. His Biochemistry study frequently draws connections to adjacent fields such as Biological activity. His multidisciplinary approach integrates Biological activity and Pharmacology in his work. He combines Drug and Biopharmaceutics Classification System in his research. Inder S. Anand merges Biopharmaceutics Classification System with Drug in his study. His In vitro study often links to related topics such as Biopharmaceutics. His Pharmacognosy research extends to the thematically linked field of Biopharmaceutics. His research on Pharmacognosy frequently connects to adjacent areas such as In vitro. His multidisciplinary approach integrates Heart failure and Inotrope in his work.

Inder S. Anand most often published in these fields:

Pharmacology (50.00%)
Biological activity (50.00%)
Drug (50.00%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber.
The New England Journal of Medicine (2019)

3207 Citations

The Seattle Heart Failure Model Prediction of Survival in Heart Failure

Wayne C. Levy;Dariush Mozaffarian;David T. Linker;Santosh C. Sutradhar.
Circulation (2006)

2109 Citations

Spironolactone for Heart Failure with Preserved Ejection Fraction

Bertram Pitt;Marc A. Pfeffer;Susan F. Assmann;Robin Boineau.
The New England Journal of Medicine (2014)

2086 Citations

Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative.

Claudio Ronco;Peter R. McCullough;Stefan D. Anker;Inder Anand.
European Heart Journal (2010)

1164 Citations

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

Inder S. Anand;Lloyd D. Fisher;Yann Tong Chiang;Roberto Latini.
Circulation (2003)

1106 Citations

Angiotensin-Neprilysin inhibition in heart failure with preserved ejection fraction

Scott D. Solomon;John J.V. McMurray;Inder S. Anand;Junbo Ge.
The New England Journal of Medicine (2019)

1102 Citations

Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure

Roberto Latini;Roberto Latini;Serge Masson;Inder S. Anand;Emil Missov.
Circulation (2007)

814 Citations

Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial

Marc A. Pfeffer;Brian Claggett;Susan F. Assmann;Robin Boineau.
Circulation (2015)

757 Citations

Consensus recommendations for the management of chronic heart failure: Introduction

Milton Packer;Jay N. Cohn;William T. Abraham;Wilson S. Colucci.
American Journal of Cardiology (1999)

694 Citations

Anemia and Its Relationship to Clinical Outcome in Heart Failure

Inder Anand;John J.V. McMurray;James Whitmore;Marshelle Warren.
Circulation (2004)

602 Citations

If you think any of the details on this page are incorrect, let us know.